[ 6 ] demonstrated that ANA-positive patients are more prone to developing significant ATI titers compared to patients who remain ANA-negative with a borderline significant relationship.
← all excerpts
Antinuclear antibodies seroconversion and endoscopic response to infliximab in biologic-naive Crohn's disease: a Chinese single-center, retrospective study.
1
—
—